Ozempic is the injectable peptide GLP-1 medicine with the most FDA-approved uses in type 2 diabetes, with indications to improve blood sugar along with diet and exercise, to reduce the risk of major cardiovascular events (heart attack, stroke, or death) in adults who also have known heart disease, and to reduce the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease
Clinical evidence demonstrates that GLP-1 RAs are an effective means of reducing the risk of MACE in diabetic patients
By understanding your bodys response and monitoring symptoms, you can work with your healthcare provider to achieve the best possible outcomes while using this medication
364,365,366 Unlike other delivery carriers, INPs possess a stable and robust structure, a large specific surface area, and tunable surface properties, allowing precise control of the drug delivery process through surface functionalization and controlled release modifications